Objective: The aim of this study is to evaluate the diagnosis and treatment results of patients who underwent endoscopic surgery in our clinic due to malignant paranasal sinus tumors.
Material and Methods: Between January 2009 and December 2018, the files of patients with malignant paranasal sinus tumors, who were treated with endoscopic surgery only, without combining it with open surgery, were evaluated retrospectively. Demographic data, histopathological diagnosis, surgical characteristics, postoperative complications, and treatment results were determined.
Results: A total of 15 patients, consisting of 7 males and 8 females, aged 17–84 years (average of 50.13) were included in the study. The most common symptom was nasal obstruction, followed by epistaxis. Histopathologic diagnosis was adenocarcinoma in 4 patients; olfactory neuroblastoma in 3 patients; hemangiopericytoma in 2 patients; and squamous cell carcinoma, malignant melanoma, adenoid cystic carcinoma, sinonasal differencing carcinoma, and small cell carcinoma in the remaining patients. The diagnosis of malignant mesenchymal tumor and extramedullary plasmacytoma was determined as two separate histopathologic diagnoses in 1 patient. The average follow-up period was determined as 33.3 months. Ten patients received postoperative adjuvant therapy, and 4 patients developed local recurrence.
Conclusion: In patients with malignant paranasal sinus tumors, if negative surgical margins could be achieved with endoscopic surgery, endoscopic techniques have become more preferred today due to low morbidity rates. Successful oncologic results can be obtained with adjuvant therapies, even if there is a positive surgical margin with endoscopic surgeries.
| Primary Language | English |
|---|---|
| Subjects | Otorhinolaryngology |
| Journal Section | Original Article |
| Authors | |
| Publication Date | December 7, 2019 |
| Published in Issue | Year 2019 Volume: 2 Issue: 3 |
You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104
Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.